Eiger BioPharmaceuticals, Inc. (EIGR)
Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.
Address
2155 PARK BOULEVARD
PALO ALTO, CA 94306
Founded
2008
Number of Employees
56
Website
http://www.eigerbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)